The QualityStocks Daily Tuesday, February 10th, 2026

Today's Top 3 Investment Newsletters

Schaeffer's(SPOT) $476.0200 +14.75%

Earnings360(GCMG) $11.3000 +14.14%

Tiny Gems(RVSN) $6.5900 +11.69%

The QualityStocks Daily Stock List

ZW Data Action Technologies (CNET)

Wall Street Resources, StockEarnings, StockMarketWatch, SmarTrend Newsletters, MarketClub Analysis, TradersPro, QualityStocks, BUYINS.NET, Marketbeat.com, Jason Bond, TraderPower, MarketBeat, OTCPicks, InvestorPlace, Schaeffer's, StockOodles, Stock Analyzer, StreetInsider, PennyStocks24, BullRally, Money Morning, CoolPennyStocks, CRWEFinance, CRWEPicks, Dynamic Wealth Report, CRWEWallStreet, HotOTC, Hit and Run Candle Sticks, FeedBlitz, DrStockPick, OTCtipReporter, MadPennyStocks, PoliticsAndMyPortfolio, Wall Street Mover, TopPennyStockMovers, The Street, The Online Investor, StockRich, StockHotTips, StockEgg, Rick Saddler, PennyOmega, Premium Stock Alerts, Penny Pick Finders, PennyToBuck, PennyStockVille, PennyStockScholar, PennyStockProphet, BestOtc, PennyInvest, Penny Stock, Penny Sleuth and Profitable Trader Authority reported earlier on ZW Data Action Technologies (CNET), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ZW Data Action Technologies Inc. (NASDAQ: CNET) (FRA: CSN1) offers data analysis, precision marketing, omni-channel advertising, member points management, online to offline sales channel expansion and other value added services to medium and small enterprises in China.

ZW Data Action Technologies serves consumers across the globe and has its headquarters in Beijing, the People’s Republic of China. The firm was established in 2003 by Zhi Ge Zhang and Han Dong Cheng and is party to a cooperation agreement with Shenzhen WePay Technology Co. Ltd.

ZW Data Action Technologies Inc. was known as ChinaNet Online Holdings Inc. before changing its name in October 2020. The firm mainly operates through the Television advertising segment and the Precision marketing, Internet advertising and Related data services segment. The former segment offers TV advertising services to help promote clients’ brands, products and services while the latter segment offers advertisers tools to develop sales channels directly in the form of resellers, distributors, sales agents and franchisees.

ZW Data Action Technologies provides internet advertising via its internet portals, such as liansuo.com and 28.com and distributes television shows that include of advertisements. This is in addition to providing cloud platforms which conduct full industry chain related data analysis that covers operation, marketing and final consumption automatically to help improve decision making for medium-sized and small business owners. The firm provides technical support services for block chain businesses and also takes part in research and development.

ZW Data Action Technologies (CNET), closed Tuesday's trading session at $1.04, up 49.9834%, on 22,324,503 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $0.6/$2.78.

Texas Mineral Resources (TMRC)

QualityStocks, InvestorIntel, RedChip, TradersPro, TopPennyStockMovers, OTC Markets Group and MarketBeat reported earlier on Texas Mineral Resources (TMRC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Texas Mineral Resources Corp. (OTCQB: TMRC) is a company focused on acquiring, exploring for, and developing mineral properties.

The firm has its headquarters in Sierra Blanca, Texas and was incorporated in 1970. Prior to its name change in March 2016, the firm was known as Texas Rare Earth Resources Corp. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The company serves consumers in the United States.

Texas Mineral Resources’ portfolio comprises of its flagship project, Rare Earths-Round Top, which is located in Hudspeth County, Texas; approximately 85 miles southeast of El Paso. It holds 19-year renewable leases from the State of Texas on 950 acres encompassing Round Top and additional prospecting permits on adjacent areas covering an additional 9,345 acres. Round Top develops a metallurgical process to concentrate or otherwise extract the metals from the project's rhyolite, conduct additional engineering, design and geotechnical work, among others. The enterprise’s Carlisle mine has four patented mining claims totaling sixty-three acres in the Steeple Rock district of New Mexico. This is in addition to pursuing other potential domestic mining opportunities, primarily gold and silver.

The company recently announced that its venture partner, USA Rare Earth, had signed a letter of intent with the U.S. government for $1.6 billion in funding to accelerate the domestic heavy rare earth supply chain. This move may open Texas Mineral Resources up to additional revenues and help extend its reach while also generating additional value for its shareholders.

Texas Mineral Resources (TMRC), closed Tuesday's trading session at $1.08, off by 0.9174312%, on 152,514 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.3675/$3.02.

Canaan Inc. (CAN)

CryptoCurrencyWire, BillionDollarClub, CurrencyNewsWire, QualityStocks, MarketClub Analysis, Schaeffer's, StockEarnings, InvestorPlace, MarketBeat, TradersPro, AllPennyStocks, StreetInsider, Stockhouse, Investors Alley, Dividend Report, Energy and Capital, INO Market Report, Investment Insights Report, Acorn Wealth, The Online Investor, Wealth Daily, InvestorsUnderground, Premium Stock Alerts, StocksEarning, Early Bird, SmarTrend Newsletters, TopStockAnalysts, Stock Fortune Teller, BUYINS.NET, Trades Of The Day, StockMarketWatch and The Street reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Crypto markets are known for their speed, size, and surprises. But even in this fast-moving world, what happened at a South Korean crypto exchange shocked many people. A simple mistake turned into a $40 billion problem almost instantly.

The company involved is Bithumb, one of South Korea’s largest cryptocurrency exchanges. The firm planned to give customers a small reward as part of a routine promotion. Each user was supposed to receive 2,000 won, which is worth about $1. Instead of sending cash, the system mistakenly sent 2,000 bitcoins to each affected customer. At current prices, that error added up to more than $40 billion worth of bitcoin.

For a short moment, 695 customers suddenly became extremely wealthy on paper. However, the excitement did not last long. Bithumb detected the error within 35 minutes and quickly stepped in. The company froze trading and withdrawals for the affected accounts to stop the situation from getting worse.

According to Bithumb, about 620,000 bitcoins were sent out by mistake. The exchange later said it had recovered 99.7% of the coins, meaning only a very small portion could not be immediately returned. The company also made it clear that the issue was not caused by hackers or a cyberattack. Instead, it was an internal system error.

Bithumb publicly apologized and tried to reassure users. The company said customer funds were not at risk and that its security systems were still strong. To make up for the disruption, Bithumb announced compensation for users who were active at the time. These customers will receive 20,000 won, which is about $13, and the exchange will temporarily waive trading fees. The company also promised to upgrade its systems, including using artificial intelligence to detect unusual transactions before they happen.

The incident quickly caught the attention of South Korea’s financial authorities. The Financial Supervisory Service held an emergency meeting and said it would review the situation. If any illegal activity is found, a formal investigation will follow. Bithumb has said it will fully cooperate with regulators.

This event has restarted debates about regulation in both crypto and traditional finance. While crypto is often seen as risky, mistakes like this are not limited to digital assets. In 2024, a major U.S. bank accidentally credited $81 trillion to a customer due to human error before reversing the transaction.

The lesson is simple. Technology can move money fast, but even small mistakes can create massive consequences. As crypto continues to grow, stronger controls and better safeguards will be just as important as innovation.

Other crypto entities like Canaan Inc. (NASDAQ: CAN) would do well to pick up lessons from what happened to the Korean exchange and strengthen their systems so that errors don’t result in reputational losses or financial losses.

Canaan Inc. (CAN), closed Tuesday's trading session at $0.565, off by 6.8732%, on 13,257,603 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $0.5/$2.22.

Bullish (BLSH)

MarketClub Analysis, MarketBeat, Zacks, Top Pros' Top Picks, The Night Owl, The Motley Fool, StockReport, Premium Stock Alerts, Pivot & Flow, OTCPicks, Earnings360 and 360 Wall Street reported earlier on Bullish (BLSH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Concerns about China’s stance on digital assets have resurfaced as Bitcoin drifts deeper into bear market conditions. Chinese authorities have announced a tighter interpretation of their existing cryptocurrency ban, moving to explicitly outlaw activities tied to real-world asset (RWA) tokenization and unapproved stablecoins tied to the yuan.

In a joint action led by the People’s Bank of China alongside multiple enforcement agencies, Beijing made clear that its stance on crypto remains unchanged. Although trading and mining were effectively outlawed in 2021, the latest guidance is designed to close gaps that allowed some investors and companies to maintain indirect exposure through overseas platforms and products.

While many countries view RWA as a way to modernize settlement systems and improve market efficiency, Chinese officials see the trend as a potential source of financial risk. Chinese regulators argue that such instruments can encourage speculation and complicate oversight, especially when issued beyond the country’s borders.

The directive also takes aim at digital currencies pegged to the yuan. China has long guarded control over its currency, and officials have repeatedly warned against private alternatives that could undermine monetary authority. Unauthorized stablecoins linked to the yuan are now explicitly categorized as illegal, regardless of where they are issued.

The notice applies what regulators described as a principle of equal treatment. It states that no individual or organization is allowed to create offshore stablecoins tied to the yuan without approval. The measure effectively shuts the door on foreign crypto firms seeking to offer yuan-based products to users with ties to China. Analysts view the move as part of a broader effort to limit capital outflows and maintain strict oversight of financial flows.

China’s position stands in sharp contrast to other nations. Hong Kong is moving ahead with plans to become a regulated center for crypto, including a licensing framework for stablecoins expected to launch soon.

In the US, major financial institutions are exploring blockchain-based products, even as lawmakers struggle to agree on comprehensive rules. Other regions, including parts of Africa, are testing local currency stablecoins rather than banning them outright.

For investors, the message is clear. Digital assets may operate on global networks, but regulation remains firmly rooted in national policy. Projects connected to Chinese assets or demand may encounter additional barriers, while those based in clearer regulatory environments could find themselves at an advantage.

Major actors like Bullish (NYSE: BLSH) in the international crypto space will be taking note of any regulatory developments that could impact their long-term strategic plans in the markets in which they wish to establish a presence.

Bullish (BLSH), closed Tuesday's trading session at $32.05, even for the day, on 4,043,235 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $24.79/$118.

Rivian Automotive Inc. (RIVN)

BillionDollarClub, Green Car Stocks, Schaeffer's, QualityStocks, InvestorPlace, MarketClub Analysis, MarketBeat, The Street, Kiplinger Today, StockEarnings, Early Bird, INO Market Report, Investopedia, Financial Newsletter, The Online Investor, Zacks, GreenCarStocks, AllPennyStocks, FreeRealTime, Daily Trade Alert, TipRanks, The Night Owl, InsiderTrades, StocksEarning, Trades Of The Day, Louis Navellier, DividendStocks, InvestorsUnderground, InvestorIntel, StockReport, Cabot Wealth, Chaikin PowerFeed, Top Pros' Top Picks, Premium Stock Alerts, 360 Wall Street, Market Munchies, bullseyeoptiontrading, Earnings360, Elite Trade Club, Hit and Run Candle Sticks, Jeff Bishop, Premium Stock Picks, Prince Report, Rick Saddler, Top Pros’ Top Picks and Investors Underground reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

China has begun producing sodium-ion electric vehicles, moving ahead of Western automakers like Tesla and opening the door to a new category of EVs. CHANGAN Automobile recently unveiled an electric passenger car powered by a sodium-ion battery supplied by CATL, with volume production expected to begin later this year. 

CATL serves as CHANGAN’s exclusive sodium-ion battery partner, supplying Naxtra batteries across the automaker’s full lineup, including Deepal, UNI, Qiyuan, and AVATR. 

CATL’s Naxtra battery delivers an energy density of 175 watt-hours per kilogram, signaling readiness for commercial deployment. A Cell-to-Pack design helps reduce overall weight while enabling an estimated driving range of about 400 kilometers. Cold-weather performance is another standout feature, with the battery retaining more than 90% capacity at minus 40 degrees Celsius and remaining operational at temperatures down to minus 50 degrees Celsius. 

Safety testing included crushing, drilling, and sawing, with the battery continuing to function without producing smoke or flames. While sodium-ion batteries are heavier than lithium-ion alternatives, they offer tradeoffs through lower-cost supply chains, strong cold-climate performance, and the potential for faster charging. 

One of CATL’s key engineering hurdles during production was reducing battery weight without eroding the cost advantages associated with this class of batteries. In the meantime, abundant raw materials, cleaner manufacturing processes, and simplified recycling all help diversify supply chains while reducing environmental impact. 

Looking ahead, projected ranges are expected to expand as production scales. Battery-electric models could reach between 310 and 372 miles, while range-extended and hybrid variants may deliver 186 to 248 miles, covering more than half of current new-energy vehicle range requirements. However, wider availability of hybrid and range-extended options could limit demand for fully battery-electric versions in some segments. 

Battery swapping represents another area where sodium-ion technology could gain traction. CATL has designed its sodium-ion batteries for compatibility across multiple automakers, supporting standardized exchange systems. By 2026, the company plans to deploy more than 3,000 Choco-Swap battery exchange stations across 140 Chinese cities, including over 600 locations in colder northern regions. 

This milestone places China ahead of Tesla, the modern pioneer of battery electric vehicles, in bringing sodium-ion passenger vehicles to market. Much like its early embrace of electric vehicles, CHANGAN is positioning itself at the forefront of another battery transition. 

Tesla, once known for reshaping the global auto industry, has yet to introduce sodium-ion batteries for light-duty EVs as its leadership has prioritized other strategic and political initiatives. Other American automakers like Rivian Automotive Inc. (NASDAQ: RIVN) could end up switching to this battery chemistry once it gains traction and customer trust. 

Rivian Automotive Inc. (RIVN), closed Tuesday's trading session at $14.96, up 1.838%, on 37,616,377 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $10.36/$22.69.

Trulieve Cannabis Corp. (TCNNF)

CannabisNewsWire, QualityStocks, InvestorPlace, MarketBeat, Wealth Insider Alert, Daily Trade Alert, Cabot Wealth, Top Pros' Top Picks, The Street, Trades Of The Day, Profit Trends, TradersPro, The Online Investor, StreetInsider and Prism MarketView reported earlier on Trulieve Cannabis Corp. (TCNNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

President Donald Trump’s executive order issued on December 18 signaled a shift in US medical cannabis policy, opening new paths for research and fueling a wave of mergers and acquisitions across the sector. However, one essential issue remains unresolved: how will patients receive medical marijuana in a way that resembles standard healthcare? 

Canada confronted this same problem years ago, and its experience offers a cautionary tale. 

In 2016, Canadian authorities broadened access to medical marijuana nationwide. While many viewed the decision as progressive, the chosen framework at the time left significant gaps. Healthcare professionals, particularly pharmacists, were largely excluded from the system. Cannabis could be authorized by physicians, but it was not prescribed in the traditional sense, nor dispensed through pharmacies. 

That structure became even more problematic after Canada legalized recreational marijuana in 2018. Many observers expected that adult-use legalization would finally bring medical marijuana into mainstream healthcare settings. Instead, the divide deepened. Doctors continued to issue general authorization documents rather than prescriptions, often without specifying dosage, formulation, or method of use. Pharmacists remained on the sidelines, unable to guide patients directly at the point of care. 

Meanwhile, recreational marijuana became widely available through retail stores and online platforms that were often more accessible than medical channels. For many patients, especially those dealing with neurological conditions, chronic pain, or nausea, the recreational market offered speed, convenience, and lower costs. Clinical oversight became a secondary concern. 

That shift carried risks. Cannabis can interact with other medications and requires careful guidance on dosing and timing—the kind of support that pharmacists offer. However, that support was largely missing. 

Within regulatory limits, some organizations tried to fill the gap. Call centers staffed by licensed pharmacists offered education on proper use, side effects, and potential interactions. Efforts were made to steer patients toward safer formulations and to apply basic pharmaceutical standards to product review. 

While patients valued that support, the model was not financially viable. Counseling could not be sustained when purchases flowed through nonmedical channels. Ultimately, the initiative ended not because demand was lacking, but because the system made true medical delivery unworkable. 

As U.S. cannabis policy continues to evolve, the country faces a similar crossroads. The central question is no longer about access alone. It is about delivery. Canada’s experience highlights the risks of prioritizing access while sidelining healthcare professionals. If marijuana is to be treated as a medication in the U.S., pharmacists will need to play a central role in providing it. 

For medical marijuana companies like Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a model that improves service to patients would be of great help in ensuring patients can access professional help as they use medical marijuana to manage their symptoms. 

Trulieve Cannabis Corp. (TCNNF), closed Tuesday's trading session at $6.72, off by 3.0303%, on 99,864 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $3.02/$11.83.

Helus Pharma (HELP)

MarketBeat and QualityStocks reported earlier on Helus Pharma (HELP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) ,  a clinical-stage pharmaceutical company developing novel serotonergic agonists to address serious mental health disorders, announced the appointment of Michael Cola as Chief Executive Officer, effective immediately, as the Company advances its pipeline toward key clinical and corporate milestones, including expected Phase 2 data for HLP004 this quarter and Phase 3 topline data for HLP003 in Q4 2026, while continuing to expand a broad global intellectual property portfolio and transition toward later-stage development, regulatory engagement, and long-term commercial planning.

To view the full press release, visit https://ibn.fm/VugQZ

About Helus Pharma

Helus Pharma(TM), the commercial operating name of Cybin Inc., founded in 2019 (the “Company”), is a clinical stage pharmaceutical company committed to helping minds heal by developing proprietary NSAs – novel serotonergic agonists: synthetic molecules designed to activate serotonin pathways that are believed to promote neuroplasticity. The Company’s proprietary NSAs are intended to address the large unmet need for people who suffer from depression, anxiety, and other mental health conditions.

With class leading data, Helus Pharma aims to improve the treatment landscape through the introduction of NSAs that aim to provide durable improvements in mental health. Helus Pharma is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of major depressive disorder that has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration and HLP004, also a proprietary NSA in Phase 2 for generalized anxiety disorder. Additionally, Helus Pharma has an extensive research portfolio of investigational NSAs.

The Company operates in Canada, the United States, the United Kingdom and Ireland. For Company updates and to learn more about Helus Pharma, visit www.helus.com or follow the team on X, LinkedIn, YouTube and Instagram. Helus Pharma(TM) is a trademark of Cybin Corp.

Helus Pharma (HELP), closed Tuesday's trading session at $6.41, up 1.4241%, on 1,122,081 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $4.81/$10.59.

VolitionRx Limited (VNRX)

RedChip, MissionIR, QualityStocks, StockMarketWatch, BUYINS.NET, PennyStocks24, Tip.us, FreeRealTime, MarketBeat, MarketClub Analysis, Streetwise Reports, InsiderTrades, TraderPower, Tiny Gems, SeeThruEquity Research, AllPennyStocks, StockHotTips, Jeff from Bullseye Trades, TradersPro, SmallCapStockPlays, PennyOmega, DrStockPick, DreamTeamNetwork, CRWEWallStreet, CRWEPicks, CRWEFinance, PennyToBuck, BestOtc and InvestorPlace reported earlier on VolitionRx Limited (VNRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

VolitionRx (NYSE American: VNRX), a multi-national epigenetics company, announced the appointment of Medical & Biological Laboratories Co. Ltd. as a non-exclusive distributor of its Nu.Q(R) Discover assays in Japan. The agreement expands access to Volition’s nucleosome-based biomarker assays for drug developers and researchers in the Japanese market and builds on the Company’s growing global collaborator network, as Nu.Q(R) Discover now serves close to 100 clients worldwide, including leading pharmaceutical and diagnostic companies using the assays to support disease research, drug development, and late-stage clinical trials.

To view the full press release, visit: https://ibn.fm/dAB9W

About Volition

Volition is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring.

Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help detect and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early detection and monitoring have the potential not only to prolong the life of patients, but also to improve their quality of life.

Volition’s research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and an office in London.

The contents found at Volition’s website address are not incorporated by reference into this document and should not be considered part of this document. Such website address is included in this document as an inactive textual reference only.

Media Enquiries: Louise Batchelor, Volition, mediarelations@volition.com , +44 (0)7557 774620

For further information, visit the company’s website at https://volition.com/

VolitionRx Limited (VNRX), closed Tuesday's trading session at $0.245, off by 3.0471%, on 6,289,090 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.22/$0.94.

NanoViricides, Inc. (NNVC)

Tip.us, QualityStocks, MissionIR, SmallCapRelations, BioMedWire, SeriousTraders, InvestorBrandNetwork, Stocks to Buy Now, SmallCapSociety, NetworkNewsWire, StocksToBuyNow, Wall Street Resources, StockMarketWatch, TradersPro, Stock Preacher, InvestorSoup, Beacon Equity Research, PennyStocks24, MarketClub Analysis, BUYINS.NET, Jason Bond, StockProfessors, SuperStockTips, Penny Stocks Finder, StockHideout, MarketBeat, Penny Stock Craze, Stock Roach, StocksEarning, SmarTrend Newsletters, PennyStockShark, LightningStockPicks, StockEarnings, The Daily Market Alert, USA Market News, Stock Analyzer, Broad Street, CoolPennyStocks, FeedBlitz, Standout Stocks, Financial Newsletter, Penny Stock Finder, OTCPicks, StreetAuthority Daily, Market Wrap Daily, Jeff Bishop, HotOTC, MarketMovingTrends, TopStockAnalysts, uniquetokens, Tiny Gems, PennyOmega, Smart Investing Society, ProTrader, Small Caps, CRWEFinance, HotStockChat, Real Pennies, Greenbackers, RedChip, Round Up the Bulls, DrStockPick, DividendStocks, MegaPennyStocks, CRWEPicks, The Street, Stock Market Watch, BullRally, Stock Beast, SmallCapVoice, BestOtc, AllPennyStocks, All about trends, Agora Financial, CRWEWallStreet, MicroCapDaily, 360 Wall Street, StockEgg, Penny Pick Finders, Penny Invest, OTCReporter, Stock Source, StockHotTips, Morning Watchlist, Stock Rich, MicrocapVoice, InvestorPlace, Zacks, PennyTrader Publisher, PennyToBuck, MarketClub, StreetInsider, Prince Report, ProfitableTrading, The Online Investor, InvestorsUnderground and Stockwire reported earlier on NanoViricides, Inc. (NNVC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage antiviral developer, announced that it has filed an application with the U.S. Food and Drug Administration Office of Orphan Products Development for Orphan Drug Designation for NV-387 as a treatment for measles. If granted, the designation would make the Company eligible for incentives including tax credits for qualified clinical trials, exemptions from certain FDA user fees, and up to seven years of market exclusivity following approval, supporting the regulatory development of NV-387 amid rising measles cases in the United States and globally.

To view the full press release, visit https://ibn.fm/ncddW

ABOUT NANOVIRICIDES

NanoViricides, Inc. (the “Company”) (www.nanoviricides.com) is a publicly traded (NYSE-American, stock symbol NNVC) clinical stage company that is creating special purpose nanomaterials for antiviral therapy. The Company’s novel nanoviricide(TM) class of drug candidates and the nanoviricide(TM) technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The Company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments.

The Company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The Company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005.

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. Our other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. The Company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. The Company is currently focused on advancing NV-387 into Phase II human clinical trials.

The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides’ platform technology and programs are based on the TheraCour(R) nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful. As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product is extremely lengthy and requires substantial capital. As with any drug development efforts by any company, there can be no assurance at this time that any of the Company’s pharmaceutical candidates would show sufficient effectiveness and safety for human clinical development. Further, there can be no assurance at this time that successful results against coronavirus in our lab will lead to successful clinical trials or a successful pharmaceutical product.

NanoViricides, Inc. (NNVC), closed Tuesday's trading session at $1.01, up 8.0214%, on 616,011 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $0.85/$2.2299.

White Pearl Acquisition (WPACU)

We reported earlier on White Pearl Acquisition (WPACU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

White Pearl Acquisition (NYSE: WPACU) announced that it closed its initial public offering on Feb. 3, 2026, issuing 11,500,000 units at $10.00 per unit, including 1,500,000 units sold pursuant to the full exercise of the underwriters’ over-allotment option. The units began trading on the New York Stock Exchange on Feb. 2, 2026, under the symbol “WPACU,” with each unit consisting of one Class A ordinary share and one right to receive one-fifth of one Class A ordinary share upon completion of an initial business combination, while the Company’s Class A ordinary shares, units, and rights trade under the symbols “WPAC,” “WPACU,” and “WPACR,” respectively, and D. Boral Capital LLC acted as sole bookrunner for the offering.

To view the full press release, visit https://ibn.fm/TRRCk

About White Pearl Acquisition Corp.

White Pearl Acquisition Corp. is a blank check company incorporated as a BVI business company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Although there is no restriction or limitation on what industry or geographic region a target operates in, it is the Company’s intention to pursue prospective targets that are in the financial technology (FinTech), information technology (InfoTech) and business services sectors, which they believe have an optimistic growth trajectory for the coming years.

For more information, visit https://spacgrp.com/

White Pearl Acquisition (WPACU), closed Tuesday's trading session at $10.02, even for the day, on 35,996 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $10.01/$10.05.

MedWell Ai, Inc. (MWAI)

reported earlier on MedWell Ai, Inc. (MWAI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MedWell Ai (OTCQB: MWAI) announced that it has signed a letter of intent to create a vertically integrated health, wellness, and longevity platform organized across three core divisions: national pharma distribution and telemedicine, a nationwide portfolio of surgical, cosmetic, and men’s health centers, and an advanced biologics and product innovation group. The proposed consolidation includes Ageless Cosmetic Surgery Centers, Apollo BioWellness and its biologics subsidiary, and MedWell USA, with the combined company projecting more than $25 million in annual revenue in 2026 based on trailing 2025 revenues of $14 million, assuming successful closings and adequate funding, as parties move forward with due diligence targeting transaction completion within 60 days.

To view the full press release, visit https://ibn.fm/6mbb9

About MedWell Ai, Inc

Company’s business operations consist of:

(1)  MedWell USA , LLC – B2B distribution and e-commerce ordering portal for pharma products with focus on medical offices, wellness clinics, gyms and online telemedicine companies.

(2)  MedWell Direct, LLC DBA TeleMD.Ai – Developer and operator of B2B/B2C telemedicine platforms that connect consumers, corporations and its employees with licensed healthcare providers.

(3)  MedWell Facilities, LLC – This subsidiary is focused on developing and managing (1) real estate opportunities, designed to attract health and wellness tenants and (2) Ai-driven software platform, designed to optimize the operational model for weight loss, wellness, IV therapies, aesthetics, and traditional healthcare clinics through licensing model.

Please visit our websites for additional information:

MedWell Ai, Inc. (MWAI), closed Tuesday's trading session at $0.4306, off by 0.023218%, on 5,054 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $0.2/$0.8007.

Lantern Pharma (LTRN)

QualityStocks, Stocks to Buy Now, SmallCapRelations, SeriousTraders, InvestorBrandNetwork, NetworkNewsWire, AINewsWire, BioMedWire, RedChip, MarketBeat, Tip.us, InvestorPlace, Prism MarketView, TradersPro, Red Chip, Inside Trading, Early Bird, StocksTips and Premium Stock Alerts reported earlier on Lantern Pharma (LTRN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lantern Pharma (NASDAQ: LTRN) , a clinical-stage biopharmaceutical company leveraging artificial intelligence to accelerate oncology drug discovery and development, announced that Chief Executive Officer and President Panna Sharma will present at the 7th Glioblastoma Drug Development Summit, taking place Feb. 17–19, 2026, in Boston. During a Day Two presentation on Feb. 19, Mr. Sharma will highlight how the Company’s RADR® AI and machine learning platform supported the development of STAR-001, a brain-penetrant therapeutic candidate, including insights into mechanism of action, biomarker identification, indication selection, and novel combination strategies for aggressive CNS cancers such as glioblastoma and ATRT.

To view the full press release, visit https://ibn.fm/r9DaA

About Lantern Pharma

Lantern Pharma (NASDAQ: LTRN) is a clinical-stage biotechnology company using artificial intelligence, machine learning, and genomic data to streamline oncology drug development and bring precision therapies to patients who need them. The company’s proprietary RADR(R) AI platform integrates hundreds of billions of data points to identify biomarkers, predict drug response, and design smarter clinical trials. Lantern’s clinical-stage pipeline includes LP-184, LP-284, and LP-300, each targeting genomically defined patient populations.

Lantern Pharma (LTRN), closed Tuesday's trading session at $2.91, up 7.3801%, on 49,797 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $2.53/$5.7441.

The QualityStocks Company Corner

Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM)

The QualityStocks Daily Newsletter would like to spotlight Silvercorp Metals Inc. (TSX.V: SVM) (NYSE American: SVM).

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Silvercorp Metals (TSX: SVM) (NYSE American: SVM) reported financial and operating results for the three months ended Dec. 31, 2025, delivering record quarterly revenue of $126.1 million, up 51% year over year, driven by higher realized silver and gold prices and steady silver equivalent production of approximately 2.0 million ounces. The Company generated record operating cash flow of $132.9 million and free cash flow of $89.6 million, ended the quarter with $462.8 million in cash and short-term investments, and reported adjusted net income attributable to equity shareholders of $47.9 million, or $0.22 per share, while a reported net loss reflected a non-cash mark-to-market charge on convertible notes.

To view the full press release, visit https://ibn.fm/sXaQ5

Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) is a Canadian mining company producing silver, gold, lead, and zinc, with a long history of profitability and growth. The company focuses on creating shareholder value by generating free cash flow from long-life mines, expanding through organic growth opportunities in China and Ecuador, and pursuing strategic mergers and acquisitions. Silvercorp has built a reputation as a low-cost producer with a commitment to responsible mining practices.

With over 18 years of operating experience, Silvercorp has developed a diversified portfolio of mining assets and investments in China, Ecuador, and Bolivia. The company leverages its expertise in exploration and operational efficiency to enhance the value of its projects while maintaining a strong balance sheet. Silvercorp’s disciplined approach to mine expansion and resource development ensures long-term sustainable growth.

The company’s mission is to build and operate profitable mines that generate sustainable economic, social, and environmental benefits for stakeholders. Silvercorp is committed to responsible mining, with a focus on environmental stewardship and community engagement.

The company is headquartered in Vancouver, Canada.

Portfolio

Silvercorp operates a diverse portfolio of producing mines, construction-stage projects, and exploration assets across multiple jurisdictions. The company focuses on optimizing production from existing operations while strategically advancing new projects to drive future growth.

  • Ying Mining District (China) – The company’s flagship operation consists of several underground mines producing silver, gold, lead and zinc in concentrates. In fiscal 2025, Ying produced 6.9 million ounces of silver and 7,495 ounces of gold, along with lead and zinc by-products. Fiscal 2026 guidance calls for continued production growth as ongoing mine optimization efforts continue to bear fruit.
  • GC Mine (China) – A silver-lead-zinc mine with a history of consistent production and ongoing resource expansion through drilling. While production dipped slightly in fiscal 2025, output is expected to increase in fiscal 2026.
  • El Domo (Ecuador) – A fully-permitted, copper-gold project under construction. In April 2025, Silvercorp announced a detailed and fully-funded $240.5 million construction plan. Major contracts have been awarded and construction activities are underway, with commissioning expected by December 2026.
  • Condor Project (Ecuador) – A gold exploration asset with significant resources. In May 2025, Silvercorp published an updated mineral resource estimate focusing on high-grade underground zones. A revised PEA is expected by the end of 2025, alongside continued permitting and community engagement efforts.
  • Kuanping Project (China) – A permitted gold-lead-zinc satellite project north of Ying. Mine construction is underway and Kuanping will be an underground mine with ore to be milled at the Ying complex.
  • BYP Mine (China) – A gold-lead-zinc project that operated previously and is now undergoing permitting as a gold mine.
  • Bolivian Assets – Silvercorp holds a 28% stake in New Pacific Metals (TSX: NUAG, NYSE American: NEWP), providing indirect exposure to two world class silver projects: Silver Sand and Carangas.

Through its diversified portfolio, Silvercorp delivers exposure to operations generating growing cash-flow, as well as high-potential growth projects that will create long-term value for shareholders.

Market Opportunity

The global demand for silver, gold, and base metals remains strong, driven by industrial applications, investment demand, and renewable energy initiatives. Silvercorp is well positioned to capitalize on rising silver demand, particularly in China, where 80% of the world’s solar panels are manufactured—an industry heavily reliant on silver.

Ecuador’s mining sector is experiencing rapid growth, with government support for foreign investment and infrastructure improvements. Mining exports in the country surged from $275 million in 2018 to $3.3 billion in 2023, highlighting the sector’s increasing economic importance. Silvercorp’s El Domo and Condor projects are poised to become key contributors to Ecuador’s mining expansion.

Industry forecasts indicate continued growth in silver and base metal prices, benefiting producers with strong operational performance and cost controls. Silvercorp’s diversified asset base and low-cost production profile provide resilience against market fluctuations, positioning the company for long-term value creation.

Leadership Team

Rui Feng, Ph.D., Chairman & CEO, founded Silvercorp and has over 30 years of experience in mineral exploration and mining. He has been instrumental in leading the company’s strategic vision, transforming it into a profitable, low-cost silver producer with a diversified asset base. Under his leadership, Silvercorp has expanded its global footprint, acquiring and developing high-value mining projects across China, Ecuador, and Bolivia. Dr. Feng’s expertise in geology and resource development has contributed to major mineral discoveries, and his disciplined approach to capital allocation has positioned the company for long-term growth.

Derek Liu, MBA, CGA, CPA, Chief Financial Officer, brings over two decades of financial leadership experience in the mining sector, overseeing capital allocation, financial strategy, and risk management. He has played a crucial role in maintaining Silvercorp’s strong balance sheet and financial discipline, ensuring the company remains well-capitalized for organic growth and strategic acquisitions. His expertise in financial planning, compliance, and investor relations has supported Silvercorp’s continued profitability and operational efficiency in a competitive global mining landscape.

Lon Shaver, CFA, President, has extensive experience in corporate finance, equity research, and capital markets, providing strategic guidance on business development and investor relations. Before joining Silvercorp, he held senior roles in investment banking and asset management, where he advised mining companies on financing, mergers, and acquisitions. His deep understanding of capital markets and industry dynamics helps drive Silvercorp’s corporate growth initiatives, enhance shareholder value, and strengthen relationships with institutional investors and stakeholders.

Investment Considerations
  • Fiscal 2025 marked record revenues of nearly $299 million, with silver production of 6.9 million ounces and 11% year-over-year growth in silver equivalent output.
  • The company maintains industry-leading margins with an all-in sustaining cost of $12.12 per ounce of silver over the last 12 months, reinforcing its position as a low-cost producer.
  • The company maintains a strong balance sheet with over $369 million in cash and a strategic equity portfolio, ensuring financial flexibility for future growth.
  • The company launched construction of its fully funded El Domo copper-gold mine in 2025, with production expected by the end of 2026.
  • Silvercorp has published an updated mineral resource estimate for the Condor Project and expects to issue a revised PEA by year-end 2025.
  • Silvercorp is committed to strong environmental and social governance practices, holding an MSCI ESG rating of “A” and prioritizing local employment and procurement.

Silvercorp Metals Inc. (NYSE American: SVM), closed Tuesday's trading session at $10.88, up 0.9276438%, on 5,992,282 volume. The average volume for the last 3 months is 7,720,948 and the stock's 52-week low/high is $3.15/$14.

Recent News

Perpetuals.com Ltd. (NASDAQ: PDC)

The QualityStocks Daily Newsletter would like to spotlight Perpetuals.com Ltd. (NASDAQ: PDC).

Perpetuals.com focuses on 24/7, self-clearing trading venues that remove reliance on traditional clearing houses, representing an ethical alternative to questionable offshore exchanges and prediction markets.

Proprietary machine learning tools are used to analyze risk and profit-and-loss probabilities at the trade level, with a dependable platform designed to comply with MiFID II and MiCA regulatory frameworks.

The company's Ledgera platform enables low-cost, cross-chain settlement with quantum-resilient security.

Perpetuals.com (NASDAQ: PDC) , a fintech company focused on AI-driven digital asset trading solutions and regulated market infrastructure, is positioning itself at the intersection of traditional financial infrastructure and blockchain-based systems, targeting institutions that want exposure to digital assets without stepping outside regulated frameworks. The company develops software that allows regulated trading venues to operate continuously, with self-clearing and blockchain-native settlement replacing legacy post-trade processes.

Perpetuals.com (NASDAQ: PDC) announced the launch of Barrier Futures, a proprietary, MiFID II-compliant derivatives product designed as a regulated alternative to offshore perpetual futures and retail contracts for difference, addressing markets that collectively represent multi-hundred-trillion dollars in annual notional volume. The Company said Barrier Futures offer defined-risk positions without margin calls while enabling brokers to participate through a scalable B2B model that includes trading fee revenue shares, spread participation, and white-label licensing, with the platform expected to go live for qualified brokers in March 2026 and initial partnerships targeted for Q1.

To view the full press release, visit https://ibn.fm/oxzaG

Perpetuals.com Ltd. (NASDAQ: PDC) is a publicly traded, regulated digital market infrastructure company enabling derivatives trading through a compliant, API-driven platform. Built as infrastructure rather than a balance-sheet exchange, the company provides brokers, institutions, and trading venues with regulated access to crypto and tokenized derivatives while avoiding custody, credit, and counterparty exposure by design.

The platform addresses a structural gap created as demand for leveraged digital asset exposure has outpaced the availability of compliant market infrastructure, particularly in Europe. Regulatory constraints limit how traditional brokers can legally offer crypto leverage, while many existing trading venues operate outside regulated frameworks. Perpetuals is designed to function within these constraints by combining institutional-grade execution, real-time settlement, and structured product capabilities under an EU-regulated market framework.

By operating as a regulated trading venue and infrastructure provider, Perpetuals enables market participants to access derivatives through transparent and auditable systems rather than offshore or unregulated alternatives.

Platform & Infrastructure

Perpetuals operates a regulated hybrid exchange built on proprietary infrastructure and structured around an EU Multilateral Trading Facility (MTF) framework. The platform is designed as institutional trading infrastructure, incorporating a high-speed matching engine, real-time settlement, built-in compliance and surveillance, and a hybrid architecture that delivers centralized exchange performance with blockchain-based transparency.

The platform is API-native by design, enabling direct integration with CFD brokers, institutional counterparties, and trading venues. Through turnkey APIs, partners can integrate order routing, execution, structured product issuance, market data, settlement, risk management, and compliance reporting, while the platform is designed to avoid custody of client assets and balance-sheet exposure. This infrastructure-first model allows Perpetuals to function as a regulated trading venue rather than a trading counterparty.

On top of this infrastructure, the platform is designed to support crypto spot trading, perpetual futures, futures, options, swaps, and tokenized structured products, including regulated knock-out instruments intended to operate within European regulatory constraints. Perpetuals also incorporates a prediction and insight engine designed to reward accurate market signals while generating datasets used to refine pricing, risk parameters, and trading intelligence across its structured products.

Market Opportunity

Perpetuals operates at the intersection of several large and converging markets, including crypto derivatives, regulated trading infrastructure, CFD brokerage technology, and tokenized financial products. The global crypto perpetual futures market processes approximately $2.18 trillion in monthly trading volume, while Europe’s CFD market generates roughly $17.34 trillion in monthly notional volume from approximately 4.9 million active retail accounts.

European regulatory frameworks restrict CFD brokers from legally offering high-leverage crypto products, creating a significant gap between trader demand and compliant market access. As a result, demand for crypto leverage has outpaced the availability of regulated infrastructure capable of serving brokers and institutional participants. This dynamic has left a large segment of retail and professional trading activity without compliant, onshore solutions.

Perpetuals addresses this gap by enabling regulated knock-out and structured products that allow leveraged crypto exposure without breaching leverage caps. In parallel, the emergence and adoption of tokenized financial instruments and real-world assets have increased demand for compliant, multi-asset trading venues. By operating within a regulated MTF framework and supporting tokenized issuance and trading, Perpetuals enables participation in the ongoing institutional adoption of digital asset markets without reliance on offshore or unregulated systems.

Leadership Team

Patrick Gruhn is an entrepreneur, lawyer, software engineer, and fintech innovator with more than two decades of experience across technology, law, and financial markets in Europe and the United States. He has founded and scaled multiple technology companies spanning tokenized securities, legal technology, and digital infrastructure, including businesses later acquired by major industry participants. His work focuses on the intersection of blockchain, regulation, and artificial intelligence. Gruhn is also actively involved in academic and institutional initiatives related to digital innovation.

Robin Matzke is a legal and regulatory specialist with deep expertise in digital securities, tokenization, and market structure. He has founded and advised companies operating at the intersection of law and financial technology and has contributed to the development of legal frameworks for digital assets in Europe. His background includes doctoral research on virtual stock structures and extensive academic teaching and publication. Matzke has also served as an advisor on digital securities regulation at the legislative level.

Nayia Ziourti is a regulatory lawyer with more than 15 years of experience in European financial services regulation, compliance strategy, and governance. She has held senior legal and regulatory roles across both public authorities and private financial institutions, including leadership positions within EU-regulated digital asset entities. Her experience includes direct involvement with EU policy development, ESMA initiatives, and MiFID-related regulatory frameworks. Ziourti brings deep institutional knowledge of compliance implementation across complex jurisdictions.

Sean Prescott is a technologist and financial infrastructure architect with over 20 years of experience spanning fintech, cybersecurity, encryption, and decentralized systems. His background includes designing institutional trading infrastructure, secure settlement systems, and large-scale financial platforms across Europe, the Middle East, and North America. He has developed proprietary transaction and custody architectures used by governments, enterprises, and digital asset platforms. Prescott’s focus is on building secure, scalable infrastructure for regulated digital finance.

Stephen Stephens is a senior operations and technology executive with extensive experience scaling complex fintech, regtech, and enterprise platforms. His career includes leading global delivery teams, managing multimillion-dollar programs, and transitioning advanced technologies into stable operating environments. He brings expertise in operational execution, platform integration, and enterprise process management across regulated industries. Stephens has overseen large-scale implementations spanning trading systems, ERP platforms, and compliance-driven operations.

Aaron Rudder is a finance and economics professional focused on developing fairer and more efficient capital markets through regulated digital infrastructure. He brings experience across crypto finance, derivatives research, and tokenized market structures, including work within EU-regulated trading environments. Rudder has led research initiatives supporting compliant derivatives issuance and structured digital asset products. His background combines financial modeling, market analysis, and applied research at the intersection of regulation and emerging financial systems.

Investment Considerations
  • Perpetuals operates as a regulated, infrastructure-first trading venue designed to enable compliant digital asset derivatives without assuming balance-sheet or counterparty exposure.
  • The platform addresses a structurally underserved market created by regulatory constraints that limit how CFD brokers can legally offer crypto leverage in Europe.
  • An API-native architecture enables direct integration with brokers and institutional counterparties, allowing access to large existing trading bases without relying on direct retail acquisition.
  • Diversified revenue streams include trading fees, tokenized structured products, platform licensing, idle-capital yield, and hedging income across multiple market segments.
  • Operation under an EU Multilateral Trading Facility framework supports multi-asset trading and positions the platform within the regulated evolution of digital asset markets.

Perpetuals.com Ltd. (NASDAQ: PDC), closed Tuesday's trading session at $4.16, up 2.2113%, on 31,920 volume. The average volume for the last 3 months is 198,650 and the stock's 52-week low/high is $1.64/$10.5.

Recent News

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF)

The QualityStocks Daily Newsletter would like to spotlight MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF).

As an abundant element in the universe, hydrogen has an extensive range of applications, among them its use as a carrier of clean energy in fuel cells in cars and in oil refining. With the automotive industry continuously expanding, the demand for alternative fuels like hydrogen has grown exponentially. Having recognized the opportunity this presents, the state of Michigan launched an initiative focused on exploring clean energy sources like nuclear power and natural gas at the start of this year. In her announcement, Governor Gretchen Whitmer emphasized that the state possessed unique geological features that were uncommon in other parts of the country, giving it a distinct advantage in developing this energy source. For the success of this recently launched initiative, various state departments are expected to coordinate their efforts and submit a comprehensive set of technical reports by April 1st. These reports will examine key considerations, including economic benefits, potential environmental effects, and the infrastructure needed to support geologic hydrogen development. Overall, the development of geologic hydrogen presents major economic potential for Michigan, including investment attraction, job creation, and industrial growth. With rising demand for affordable, low-carbon energy, geologic hydrogen offers a faster path to net-zero emissions, positioning the state to emerge as a future hydrogen hub. Enterprises like MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) operating in Canada are also focused on advancing geologic hydrogen as a viable fuel alternative to meet the growing push to phase out dirty fuels around the world. 

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) is a Canadian mineral exploration company pioneering the development of natural hydrogen as a potential new primary energy source. As a first mover in this emerging sector, the company has assembled North America’s largest permitted land package targeting naturally occurring, emissions-free hydrogen accumulations in the earth’s subsurface.

MAX Power plans to commence Canada’s first dedicated deep drilling program for natural hydrogen in November 2025, starting on the 200-km-long Genesis Trend in southern Saskatchewan, with the goal of converting a discovery into the world’s first commercial natural hydrogen venture in 2026.

Backed by institutional partnerships and a highly experienced technical team, MAX Power continues to build a globally recognized brand in the natural hydrogen sector. Its massive land package in Saskatchewan currently comprises 1.3 million permitted acres with another 5.7 million acres under application.

Saskatchewan, a jurisdiction recognized for its supportive regulatory environment and clean energy innovation, features North America’s most advanced policy framework for the exploration and development of natural hydrogen. The province is also known for its spectacular resource endowment as the world’s leading potash provider, the top high-grade uranium producer in the world, and Canada’s second-largest oil producer. Saskatchewan is also Canada’s leader in helium production, geothermal energy and carbon capture.

The company’s head offices are in Saskatchewan’s two largest cities, Saskatoon and Regina.

Projects

Natural Hydrogen (Saskatchewan)

MAX Power holds multiple large land packages across Saskatchewan prospective for deposits of natural hydrogen, highlighted by the 200-km-long Genesis Trend and the 75-km-wide Grasslands Project.

Genesis features easy road, rail and power access and a proposed hydrogen hub on its eastern side where there is an abundance of potential end-users for natural hydrogen. Drilling is set to begin in early November 2025 at the Lawson target situated in the heart of Genesis. Canada’s first deep well for natural hydrogen is specifically designed to test a complete five-element hydrogen system interpreted to exist at Lawson: source rocks, migration pathways, reservoirs, seals, and traps. Data from vintage and proprietary 2D seismic, gravity and magnetic surveys, and subsurface mapping, among other geological and geophysical information, support the prospectivity of Lawson which lies adjacent to an extensive regional “Salt Barrier” offering excellent seal and trap conditions.

The Genesis Trend’s scalability is further demonstrated by the recent identification of the Lucky Lake target, approximately 50 km northwest of Lawson and one of at least 20 Lawson “look-a-likes” that is being investigated along the trend. Early interpretation suggests serpentinized rocks and structural features favorable for hydrogen generation exist at Lucky Lake.

At Grasslands, geologists are excited about a broad area in the vicinity of a well (“Climax”) near the U.S. border that was drilled a few years ago and inadvertently resulted in Canada’s first known deep subsurface occurrence of natural hydrogen, associated with a rare rock assemblage geologists refer to as “exotic terrane”. Permits covering an area stretching 75 km east-west and up to 10 km north-south were acquired by MAX Power next to this discovery, amplifying the company’s first-mover advantage. Adjacent to three sides of Grasslands are producing helium wells owned by privately-held North American Helium, demonstrating that this under-explored area of the province is highly prospective for clean gas. Drilling of a target at Grasslands is expected during Q1 2026.

Other MAX Power land packages are Rider 1, 2 and 3 in the southeast part of the province, and Choiceland in the north-central part of the province.

To enhance scientific rigor and accelerate development, MAX Power has established a multi-year strategic collaboration with the Petroleum Technology Research Centre (PTRC), a globally recognized leader in subsurface energy research based in Regina, Saskatchewan. This partnership complements the company’s relocation to Innovation Saskatchewan’s R+T Parks in Saskatoon and Regina, placing its technical and executive teams at the heart of the province’s academic, regulatory, and infrastructure ecosystem.

Critical Minerals

MAX Power’s other key asset is its Wilcox Lithium Project in mining-friendly Cochise County in southeast Arizona where first-ever diamond drilling in late 2023/early 2024 confirmed the discovery of near-surface lithium-rich clays over a broad area of the Willcox Playa. MAX Power’s property occurs within a nearly 4,000-acre corridor adjacent to U.S. Department of Defense land, and benefits from direct access through roads, rail and power infrastructure. The discovery was made just as lithium entered its final price downturn and is now being intensely revisited by the company in light of the turnaround in lithium and an emphasis on critical mineral resource development in the United States under the Trump administration.

Market Opportunity

According to company materials, the global hydrogen market is valued at approximately $250 billion and is expected to surpass $400 billion by 2030. Supporting this outlook, a study published in Science Advances (Dec. 2024) estimates that in-place natural hydrogen resources could meet global net-zero carbon goals for roughly 200 years. Closer to home, a feasibility study by the Transition Accelerator (April 2024) projects that the Regina-Moose Jaw Industrial Corridor (RMJIC) in Saskatchewan could support a C$708 million annual hydrogen market, with province-wide demand reaching as high as C$2.7 billion per year.

These projections underscore a compelling opportunity to establish a new energy economy centered around natural hydrogen—a low-cost, low-emission, and potentially naturally replenishing resource. MAX Power is well-positioned to lead this effort with proximity to infrastructure, favorable geology, and increasing institutional support.

Leadership Team

Mansoor Jan, CEO, brings more than two decades of international experience across mining operations, capital markets, and business development. He has held senior positions at BHP Australia, BHP Chile, and Rio Tinto, where he was responsible for advancing cross-border projects, driving mine optimization, and leading technology delivery across major jurisdictions. Mr. Jan holds a BA and MSc in Economics and a Master of Commerce from the University of New South Wales in Australia.

Neil McMillan, Director and Chair of the Audit Committee, is the former Chairman of the Board of Cameco, the world’s largest publicly traded uranium company. Mr. McMillan served on Cameco’s board for 16 years and is highly regarded within and outside the province for his decades of success there. He previously led Claude Resources as President and CEO, paving the way for its development into Saskatchewan’s only profitable gold miner which was bought out for more than $300 million by Silver Standard Resources in 2014.

Steve Halabura, Chief Geoscientist, has decades of successful experience in the province’s resource sector including a deep understanding of the geological controls on the accumulation of hydrogen, helium, and other industrial gases. He was also instrumental in the early formative stages of the only two Saskatchewan greenfield potash mines to come into existence in the 21st century, these being BHP’s Jansen Project and K+S’s Bethune mine. Jansen is the largest private investment ($14 billion) in Saskatchewan history and is located northeast of MAX Power’s Genesis Trend.

Tom Kishchuk, MAX Power’s Senior Strategic Advisor for Natural Hydrogen Development, is CEO for the Saskatchewan-based Global Institute for Energy, Mines and Society (GIEMS). He has over three decades of technical and business leadership in national and global organizations focused on the energy sector.

Investment Considerations
  • First Mover Advantage: MAX Power is leading North America’s emerging natural hydrogen sector, controlling the largest permitted land position highlighted by Saskatchewan’s highly prospective Genesis Trend.
  • Historic Milestone Ahead: The company plans to drill Canada’s first dedicated natural hydrogen well in November 2025, targeting what could become the world’s first commercial-scale discovery of this clean, emissions-free energy source.
  • Global Validation and Aligned Capital: Backed by a C$5 million investment from a major Southeast Asian energy group, support from billionaire investor Eric Sprott, and partnerships with PTRC and Innovation Saskatchewan, MAX Power combines world-class credibility with long-term financial strength.
  • Generational Opportunity: With first-mover status, institutional backing, and scalable geology, MAX Power is positioned to anchor a new era of clean, reliable energy for North America’s industrial and digital future.
  • Strategic U.S. Presence: MAX Power’s Willcox Lithium Project in Arizona, bordering U.S. Department of Defense–controlled lands, strengthens its position in critical minerals vital to U.S. energy security.
  • Abundant Affordable Clean Energy: Natural hydrogen offers a low-cost, non-intermittent baseload power source, aligning perfectly with the climate mandates and surging energy needs of AI data centers, ammonia producers and industries across North America.
  • MAX Power is focused on advancing North America’s energy security and the shift to scalable, low-emission energy sources like natural hydrogen. Its strategy emphasizes responsible exploration, efficient development, and alignment with emerging clean energy demand. Through disciplined execution, the company aims to build lasting value across energy and industrial markets.

MAX Power Mining Corp. (OTC: MAXXF), closed Tuesday's trading session at $0.7328, up 2.2036%, on 65,869 volume. The average volume for the last 3 months is 512,160 and the stock's 52-week low/high is $0.105/$0.8791.

Recent News

Earth Science Tech Inc. (OTC: ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech Inc. (OTC: ETST).

Earth Science Tech (OTC: ETST) , a strategic holding company focused on acquiring and scaling high-potential operating businesses, announced that it will report financial results for the three months ended Dec. 31, 2025, after the close of trading on Tuesday, Feb. 17, 2026.

To view the full press release, visit https://ibn.fm/FnUf9

Earth Science Tech Inc. (OTC: ETST) is a strategic holding company that builds value by acquiring and actively managing operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and select consumer markets. The company focuses on controlling interests in subsidiaries where operational oversight, regulatory compliance, and disciplined scaling can drive durable growth.

Since 2022, Earth Science Tech has completed a deliberate transition away from legacy activities and repositioned the organization around healthcare and pharmaceutical operations. That shift has been supported by regulatory alignment, expanding operating capabilities, and the assembly of a diversified portfolio of revenue-generating businesses.

Today, the company’s approach emphasizes execution, capital discipline, and long-term value creation across its operating platforms, with a focus on scaling businesses that can grow sustainably while enhancing shareholder value.

The company is headquartered in Miami, Florida.

Subsidiaries

Earth Science Tech conducts its operations through a portfolio of wholly owned and majority-owned subsidiaries spanning pharmaceutical compounding, telemedicine, healthcare services, real estate development, and direct-to-consumer products.

  • RxCompoundStore.com LLC – A fully licensed compounding pharmacy based in Miami, Florida, authorized to fulfill prescriptions across more than 20 U.S. states and Puerto Rico, with ongoing licensure expansion efforts nationwide.
  • Mister Meds LLC – A Texas-based compounding pharmacy operating from a 5,000-square-foot facility with advanced sterile and hazardous drug compounding capabilities, acquired to expand production capacity and geographic reach.
  • Peaks Curative LLC – A telemedicine referral platform providing asynchronous consultations for Peaks-branded compounded medications, supported by an expanding provider network and recent entry into the veterinary market through Zoolzy.com.
  • DOConsultations LLC – An online telehealth platform focused on customized medication formulations, supporting direct-to-patient delivery through partner pharmacies.
  • Las Villas Health Care Inc. – A brick-and-mortar and telehealth healthcare provider serving the Spanish-speaking community, offering specialized wellness and sexual health services.
  • Avenvi LLC – A diversified real estate development and asset management company overseeing property investments, development projects, and the company’s ongoing share repurchase program.
  • MagneChef (80% interest) – A direct-to-consumer retail brand leveraging proprietary intellectual property to develop and market kitchen and cooking-related products, with recent expansion into premium American-made BBQ tools.
  • Earth Science Foundation Inc. – A 501(c)(3) nonprofit organization serving as the company’s charitable arm, providing financial assistance for prescription costs to qualified individuals.

Collectively, these subsidiaries provide Earth Science Tech with diversified exposure across regulated healthcare services, digital health platforms, real estate assets, and proprietary consumer brands.

Market Opportunity

Earth Science Tech is primarily positioned within the pharmaceutical compounding and telemedicine markets, both of which are experiencing sustained growth driven by demand for personalized healthcare solutions, expanded access to care, and increasing adoption of remote service models.

The pharmaceutical compounding market continues to benefit from rising demand for customized medications, improved patient adherence, and supply-chain flexibility. According to Grand View Research, the global compounding pharmacies market was valued at approximately $13.1 billion in 2023 and is projected to reach $18.6 billion by 2030, representing a compound annual growth rate of 5.11% from 2024 to 2030. Earth Science Tech’s compounding operations through RxCompoundStore.com and Mister Meds align directly with this expanding market segment.

Telemedicine represents a second core growth vertical for the company, supporting the clinical delivery of pharmaceutical products and healthcare services. According to Fortune Business Insights, the global telemedicine market was valued at $111.99 billion in 2025 and is projected to grow to $532.08 billion by 2034, reflecting a compound annual growth rate of 20.0%, with North America accounting for approximately 48% of market share in 2025. Platforms operated by Peaks Curative and DOConsultations participate directly in this rapidly expanding digital health ecosystem.

Additional exposure to specialty healthcare clinics and real estate development provides diversification alongside the company’s core pharmaceutical and telemedicine operations.

Leadership Team

Giorgio R. Saumat, Chief Executive Officer and Chairman of the Board, is an investor and entrepreneur with more than 20 years of experience investing in, operating, and advising private businesses, including founding CASAU Group, a private equity firm focused on real estate, and POINT96 Consulting, which provides strategic planning services to businesses and accredited investors.

Ernesto L. Flores, Chief Financial Officer, is a financial executive with over a decade of experience in accounting, taxation, and financial management, having held senior roles overseeing compliance and financial operations at logistics and investment firms.

Mario G. Tabraue, President and Chief Operating Officer, brings experience across real estate, maritime operations, and digital infrastructure and was instrumental in acquiring RxCompoundStore.com with the vision of scaling it into a nationally competitive pharmaceutical and telemedicine platform.

Christopher Rose, Chief Technology Officer, is a technology and automation executive who previously led enterprise-wide automation initiatives at a Fortune 100 company, delivering large-scale operational efficiencies and global process automation.

Investment Considerations
  • Earth Science Tech operates a diversified, revenue-generating holding company model with core exposure to pharmaceutical compounding and telemedicine markets.
  • The company has demonstrated operational execution through asset growth, profitability, and disciplined share reduction initiatives.
  • Regulatory alignment, including SIC 2834 pharmaceutical classification and FINRA Form 211 clearance, enhances transparency and market credibility.
  • A multi-subsidiary structure provides organizational flexibility across pharmaceutical, telemedicine, healthcare, real estate, and consumer operating businesses.
  • The company is led by an executive team with experience across operations, finance, technology, and strategic management, providing continuity and oversight across its operating platforms.

Earth Science Tech Inc. (OTC: ETST), closed Tuesday's trading session at $0.149, up 4.5321%, on 140,086 volume. The average volume for the last 3 months is 102,230 and the stock's 52-week low/high is $0.001/$0.237.

Recent News

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF)

Disseminated on behalf of Nevada Organic Phosphate Inc., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF).

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) , a B.C.-based organic sedimentary phosphate explorer, announced continued progress interpreting assay results from the first six drill holes in the Upper Phosphatic Zone at Murdock Mountain, confirming a weighted average grade of 10.93% P₂O₅ supported by geochemical evidence showing the material functions as a naturally balanced, multi-nutrient mineral fertilizer aligned with organic and regenerative agriculture. Ongoing analysis indicates meaningful concentrations of calcium, magnesium, silicon, iron, and other beneficial micronutrients alongside ultra-low contaminants, positioning the UPZ as a clean, low-risk phosphate source with slow-release nutrient characteristics and a potential regulatory and market advantage over conventional phosphate products.

To view the full press release, visit https://ibn.fm/PYFvX

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) is a junior exploration company focused on exploring and advancing an organic sedimentary raw rock phosphate project in northeast Nevada. The company’s business model centers on developing a rare, direct-application phosphate product that aligns with the growing demand for organic agricultural inputs. Its vision is to support the rapidly expanding organic food industry with a clean, reactive, environmentally responsible nutrient source that avoids the contamination issues associated with chemically processed fertilizers.

NOP is advancing the Murdock Mountain Project through disciplined exploration, responsible environmental practices, and strategic planning that positions the company as a future supplier of organic phosphate to key agricultural markets. The company emphasizes transparency, environmental stewardship, and adherence to regulatory standards as it advances its drill program and project development.

By developing a unique phosphate resource in a mining-friendly U.S. jurisdiction with strong infrastructure access, NOP aims to establish itself as a significant participant in the organic fertilizer sector.

The company is headquartered in Vancouver, British Columbia.

The Murdock Mountain Phosphate Project

NOP’s flagship asset is the Murdock Mountain Phosphate Project in Elko County, Nevada, a nearly flat-lying sediment-hosted phosphate system traced historically over 6.6 kilometers and extended through additional applications to more than 30 kilometers. The project’s raw rock phosphate is characterized by high purity, absence of heavy metals, and suitability for direct application without processing, aided by francolite (the most reactive crystallite structure of all P₂O₅ minerals) and oolitic textures that provide optimal surface area for interaction with soil micro-organisms. The product’s purity places it within the rare 5% of global P₂O₅ material pure enough for direct field application.

The Murdock Mountain property spans four Bureau of Land Management (BLM) applications totaling 7,824 acres, with an Exploration Target Mineral Inventory (ETMI) of 10–46 million tonnes in the initial 1,813-acre area and an additional 200–220 million tonnes across three further applications. Historic geologic mapping and recent drilling identify the Upper Phosphatic Zone within the Meade Peak Member as the primary target, with an interval historically ranging from 3.4 to 7.6 meters thick within a 28–40-meter phosphatic sequence.

In 2025, NOP commenced a multi-hole drill program with unrestricted seasonal timing following regulatory updates. Drill holes MM25-1, MM25-2, MM25-3, MM25-4 and MM25-5 all intersected favorable Meade Peak phosphate-bearing stratigraphy precisely where predicted by geological modeling. These intersections ranged from 29.2 to 38 meters (96 to 125 feet), with drilling confirming the interpreted dip and continuity of the target zone. Ongoing step-out drilling continues along the phosphate trend, supported by geological mapping and XRF screening, with assays pending. The project benefits from proximity to Highway SR 30, the hamlet of Montello, and the Southern Pacific rail line, enabling a simple mining concept summarized by: “break it up, dig it up, grind it up, bag it up, and ship it out.”

Market Opportunity

NOP intends to supply organic, direct-application phosphate fertilizer to the rapidly expanding organic food sector in North America. The company cites a $35 billion organic food market, supported by data from the U.S. Department of Agriculture’s Economic Research Service, which estimated an 8.7% annual growth rate between 2021 and 2027.

The shift toward organic and regenerative agriculture is driving demand for reactive, non-acidulated phosphate sources, and NOP notes that American farming practices are increasingly moving toward direct-application phosphate rather than soluble chemical fertilizers. With only 5% of global P₂O₅ pure enough for direct application, the company is targeting a rare, high-value segment of the fertilizer market that does not require competition with conventional chemical fertilizer producers.

Leadership Team

Robin Dow, Chairman & CEO, brings extensive experience as a public venture capital entrepreneur, following prior roles as a retail and institutional broker and researcher at Burns Fry. He has created more than 30 private and public companies across multiple sectors, raised close to $200 million, and built resource operations spanning four continents, 10 countries, four U.S. States, four Canadian provinces, and three Canadian territories.

Eric Szustak, Director, offers over 39 years of financial services, accounting, business development, and marketing experience, supported by senior roles at firms including Midland Walwyn, Merrill Lynch, and BMO Nesbitt Burns. He is the former President and current Chairman of Quinsam Capital Corporation and holds multiple directorships in publicly listed companies.

Garry K. Smith, Director, contributes more than 40 years of exploration management for companies such as Kerr Addison, Teck, Rio Tinto, and Lac Minerals. As a Qualified Person, he specializes in project generation, 43-101 reporting, resource evaluation, geological modeling, and metal ion soil geochemistry, with a strong focus on ethical and environmentally responsible exploration practices.

Paul W. Pitman, P.Geo., Director, is a field hardened veteran with extensive experience in all areas of geological exploration for a number of metals and materials. He has over 55 years’ experience as an exploration geologist. Since 1983, he has acted as a geological consultant to over 70 clients, providing a full range of services (geological, corporate, and administrative). He has served as a Director or Officer (VP or President) of several junior resource companies, including Boreal Agrominerals, a producer off organic fertilizers from igneous rock in Northern Ontario. He is semi-retired but directs his geological expertise as an advisor to several fertilizer companies.

Investment Considerations
  • NOP is advancing what it believes to be the only known large-scale organic sedimentary phosphate project in North America.
  • The company’s Murdock Mountain mineralization is uniquely pure, requiring no beneficiation and meeting the rare global threshold for direct-application P₂O₅.
  • Exploration drilling in 2025 confirmed consistent Meade Peak phosphate-bearing stratigraphy across multiple holes exactly where geological models predicted.
  • The project benefits from low-capex operational potential and immediate access to rail and road infrastructure near Montello, Nevada.
  • With an ETMI range of 210–266 million tonnes across four BLM applications, the company is targeting a large-scale organic fertilizer market growing at 8.7% annually.

Nevada Organic Phosphate Inc. (OTCQB: NOPFF), closed Tuesday's trading session at $0.1225, up 6.5217%, on 138,708 volume. The average volume for the last 3 months is 824,310 and the stock's 52-week low/high is $0.0334/$0.3212.

Recent News

GlobalTech Corp. (OTC: GLTK)

The QualityStocks Daily Newsletter would like to spotlight GlobalTech Corp. (OTC: GLTK).

Military flight training has long followed a familiar formula: structured lessons, carefully staged challenges, and instructors judging progress only by performance. In the Netherlands, researchers are now testing a system that could change that model by allowing simulators to respond directly to what is happening inside a pilot's brain

Rather than assuming how demanding a task should be, the system continuously evaluates how hard the pilot is actually working mentally. Training scenarios then adjust to match that internal workload, creating a more individualized experience. The AI also grouped mental effort into wide categories, potentially missing finer distinctions between decision-making pressure, spatial confusion, and visual stress. Similar research is underway as scientists explore whether aircraft systems can recognize startle responses or pilot stress during flight and offer timely support. While small experiments have shown promise, they caution that practical use in operational aircraft remains a distant goal. As AI makes its way into fighter pilot training, other industries are already reaping the rewards of this technology that entities like GlobalTech Corp. (OTC: GLTK) provide in clearly measurable parameters. 

GlobalTech Corp. (OTC: GLTK) is a U.S.-based technology holding company specializing in artificial intelligence (AI), big data, and digital infrastructure. Advancing toward a Nasdaq listing, the company balances internal innovation with strategic acquisitions to accelerate growth and long-term value creation.

GlobalTech’s diversified portfolio spans AI-powered solutions for enterprise productivity, e-commerce, retail, digital lending, compliance, and other high-growth domains. Flagship platforms include ThrivoAI, Cadnz, Baseball Blitz, Talina, ProtoEd, BillCare, Giftio, and EntityScan. The company also holds a majority stake in WorldCall Telecom Ltd., extending its telecommunications presence in Pakistan and supporting infrastructure-led value creation.

To strengthen market reach, GlobalTech continues to evaluate technology-centric acquisitions while also expanding through strategic regional alliances. Its partnership with significant regional players like Omantel anchors growth in the Middle East, a key gateway market. At the same time, the company’s Center of Excellence (CoE) and #GTCTalks knowledge platform position it as a thought leader in emerging technologies.

Supported by a seasoned leadership team and a disciplined execution model, GlobalTech is building sustainable momentum across global AI and big data markets, with the governance, innovation, and agility required to capture outsized opportunities in the digital economy.

Investment Considerations
  • GlobalTech balances internal innovation with strategic acquisitions to accelerate growth and long-term value creation.
  • The company’s flagship platforms span multiple high-growth domains including enterprise productivity, e-commerce, digital lending, and compliance.
  • Its majority stake in WorldCall Telecom Ltd. supports infrastructure-led value creation in Pakistan’s telecommunications sector.
  • Strategic alliances with regional players such as Omantel anchor GlobalTech’s expansion into key international markets like the Middle East.

GlobalTech Corp. (OTC: GLTK), closed Tuesday's trading session at $1.9371, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $1.1/$3.4.

Recent News

Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

One of the key advantages of photodynamic therapy is its selectivity.

Soligenix is advancing HyBryte(TM), or SGX301, designed for the treatment of cutaneous T-cell lymphoma.

The company has achieved an important safety milestone in its confirmatory phase 3 clinical trial of HyBryte for CTCL treatment.

From lab research to clinical application, photodynamic therapy ("PDT") is emerging as a powerful treatment approach that uses light and chemistry to selectively target diseased tissue. As this modality gains attention for its precision and safety profile, Soligenix (NASDAQ: SNGX) is developing light-activated therapies designed to treat cutaneous T-cell lymphoma ("CTCL") and other inflammatory skin diseases using targeted photodynamic mechanisms that aim to improve outcomes while minimizing systemic toxicity.

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Investment Considerations
  • Soligenix has multiple late-stage assets with orphan and fast-track designations, providing a clear regulatory pathway toward potential approvals.
  • The company’s pipeline has a total addressable market exceeding $2 billion, spanning rare diseases, inflammation, and biothreat applications.
  • Soligenix has benefited from significant non-dilutive government funding, which reduces operational expenses and financial risk while supporting its public health initiatives.
  • The company is well-positioned for multiple development and regulatory catalysts, and commercial milestones, with lead candidates in cutaneous T-cell lymphoma, psoriasis, oral mucositis, and Behçet’s disease.
  • Soligenix is led by an experienced management team with a strong track record of success.

Soligenix Inc. (NASDAQ: SNGX), closed Tuesday's trading session at $1.12, even for the day, on 45,591 volume. The average volume for the last 3 months is 179,886 and the stock's 52-week low/high is $1.02/$6.2299.

Recent News

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

While people have been quick to blame health insurers for the skyrocketing cost of health care in the U.S., the reality of the situation is more nuanced, and other factors have played a much bigger role in driving up costs. We explore some of those less-reported drivers of the high cost of health care in the country. For example, the law caps the rates levied by medical facilities when treating patients on Medicare. However, private insurers aren't constrained by these laws as they negotiate their rates directly with the health care facilities serving their clients. In order to be more appealing to patients on private insurance policies, hospitals are racing to upgrade their facilities. Unfortunately, the cost of these upgrades later gets passed on to patients because someone has to meet that cost. Advancements in medical care have been so impactful that between 2000 and 2022, cancer mortality has reduced by 29% while mortalities linked to HIV/AIDS have dropped by a staggering 73%One last illustration will cement the view that increased use of medical care plays a big role in driving up costs. Recent development of weight loss drugs (GLP-1 drugs) attest to this fact. Close to 50% of Americans show interest in using these drugs and in 2023 their average cost was $8,412. Naturally, the high cost of these medications will exert upward pressure on health insurance costs. All in all, the premiums charged by entities like Astiva Health are influenced by many factors and it would be inaccurate to blame rising insurance costs on just profit-seeking companies. 

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News

chart

Forward Industries Inc. (NASDAQ: FWDI)

The QualityStocks Daily Newsletter would like to spotlight Forward Industries Inc. (NASDAQ: FWDI).

Forward Industries (NASDAQ: FWDI) the leading Solana treasury company, announced that it will host a conference call on Thursday, Feb. 12, 2026, at 5 p.m. Eastern Time to discuss its financial and operating results for the three months ended Dec. 31, 2025, with financial results to be released in a press release prior to the call; the Company's executive team will host the call and webcast presentation, followed by a question-and-answer period.

To view the full press release, visit https://ibn.fm/Gi80I

Forward Industries Inc. (NASDAQ: FWDI) is building and managing a large-scale Solana (SOL) treasury, backed by some of the most influential investors in the digital asset space. The company’s strategy centers on long-term shareholder value through active participation in the Solana ecosystem, which it views as uniquely positioned to underpin future global capital markets due to its high throughput, deep economic activity, and growing developer adoption.

Through this shift, Forward Industries aims to create value by accumulating SOL and strategically deploying assets through on-chain opportunities including staking, lending, and participation in decentralized finance (DeFi). Forward also became the first U.S.-listed company to bring its common stock onto the Solana blockchain, reinforcing its focus on digital-native capital markets.

Forward Industries is headquartered in New York.

Solana Treasury Operations

In September 2025, Forward Industries closed a $1.65 billion private investment in public equity (PIPE) led by Multicoin Capital, Galaxy Digital, and Jump Crypto. The PIPE proceeds were deployed to acquire over 6.8 million SOL at an average price of $232 per token, with a portion executed on-chain via DFlow, a decentralized exchange aggregator built exclusively for Solana trading applications. The company has since staked the entirety of its treasury, actively generating yield through native Solana infrastructure and DeFi applications.

Forward’s strategy is centered on growing SOL per share, leveraging a range of tools including at-the-market (ATM) equity offerings and potential preferred equity issuance. The company is also targeting acquisitions and strategic partnerships within the Solana ecosystem to accelerate treasury yield and ecosystem alignment. As part of its infrastructure expansion, Forward tokenized its FORD shares on the Solana blockchain in collaboration with Superstate and plans to acquire an equity interest in the platform. The tokenized shares are expected to enable 24/7 trading, real-time settlement, and eligibility for use as DeFi collateral.

This shift was supported by the company’s board and executive team, whose composition reflects deep alignment with the Solana ecosystem — including leadership from Multicoin Capital and board observers from Galaxy and Jump Crypto. The company’s stated objective is to establish itself as the leading institutional participant in the Solana ecosystem, uniquely positioned to capture both economic yield and strategic exposure to one of the fastest-growing blockchain networks in the world.

Market Opportunity

Solana has emerged as the most performant blockchain in the digital asset space, processing over 8.9 billion transactions in Q2 2025 and sustaining approximately $3 billion in daily decentralized exchange (DEX) trading volume. Year to date, Solana applications have generated over $4 billion in fees and more than $1 billion in real economic value (REV), a proxy for free cash flow generated by the network.

DeFi participation, stablecoin usage, and developer activity have all grown substantially, with over $1.5 trillion in swap volume recorded through 2025. SOL staking yields have averaged over 8%, comprised of both inflationary rewards and organic yield from network activity. With 17 pending ETF applications and major institutions like BlackRock, Visa, PayPal, and HSBC integrating Solana, Forward Industries is positioned to benefit from a rising tide of institutional adoption, tokenization of real-world assets, and increased demand for high-performance blockchain infrastructure.

Leadership Team

Kyle Samani, Chairman of Forward Industries, is the co-founder and Managing Partner of Multicoin Capital, an early Solana backer and one of the largest holders of SOL. Samani contributed $25 million to the PIPE and is a key strategic leader behind Forward’s treasury roadmap.

Mike Pruitt, Interim CEO of Forward Industries, joined the board in February 2025 and was appointed Interim CEO in May. He is the founder of Avenel Financial Group and previously served as CEO of Chanticleer Holdings, bringing decades of public company leadership and capital markets experience.

Kathleen Weisberg, Chief Financial Officer of Forward Industries, was appointed CFO in July 2023 after serving as Corporate Controller since 2020. Weisberg is a CPA with prior roles at WW International, Symbol Technologies, and Ernst & Young.

Investment Considerations
  • Forward Industries is the largest publicly traded Solana treasury platform with more than 6.8 million SOL acquired to date.
  • The company raised $1.65 billion in a PIPE led by Multicoin Capital, Galaxy Digital, and Jump Crypto to fund its Solana treasury acquisition.
  • Forward generates yield through active staking, lending, and DeFi participation, increasing SOL-per-share over time.
  • The company tokenized its common stock on the Solana blockchain and plans to acquire an equity stake in Superstate to expand on-chain capital markets access.
  • Forward is led by crypto-native investors with deep strategic alignment in the Solana ecosystem.

Forward Industries Inc. (NASDAQ: FWDI), closed Tuesday's trading session at $5.03, off by 7.7064%, on 676,703 volume. The average volume for the last 3 months is 898,879 and the stock's 52-week low/high is $3.32/$46.

Recent News

Olenox Industries Inc. (NASDAQ: OLOX)

The QualityStocks Daily Newsletter would like to spotlight Safe and Green Holdings Corp. (NASDAQ: OLOX).

Olenox Industries (NASDAQ: OLOX) announced the appointment of Erik Blum and Adam Falkoff to its Board of Directors, effective Feb. 6, 2026. The appointments fill existing board vacancies, with both directors serving until the Company's 2025 Annual Meeting of Shareholders and participating in the Company's non-employee director compensation program, as Olenox adds leadership experience spanning public company turnarounds, corporate finance, public policy, and global strategic advisory.

To view the full press release, visit https://ibn.fm/O7uf5

Olenox Industries Inc. (NASDAQ: OLOX) is a diversified holding company focused on delivering innovative solutions across infrastructure, construction, energy, healthcare, and environmental sectors. Originally established in 2007 as SG Blocks, the company has evolved into a vertically integrated platform serving both public and private sector clients with modular, sustainable systems. Its operations span a range of industries unified by a commitment to efficient, scalable design and sustainability-driven development.

The company’s model centers on the production and deployment of prefabricated modular structures, energy systems, and infrastructure technologies, leveraging vertical integration and cross-sector synergies to support government agencies, medical networks, developers, and commercial enterprises. Safe and Green’s subsidiaries operate collaboratively to generate multiple revenue streams while pursuing opportunities in both traditional and next-generation infrastructure.

Safe and Green Holdings Corp. is headquartered in Miami, Florida.

Portfolio

SG Echo Manufacturing

SG Echo is the modular manufacturing arm of Safe and Green Holdings Corp., delivering prefabricated structures built from steel, wood, and repurposed shipping containers. As a Made-in-America manufacturer, SG Echo combines industry-leading machinery and skilled labor to execute modular projects for clients across the U.S. and globally. The company holds an ESR certification from the International Code Council for repurposed containers, enabling faster approvals and widespread applicability in commercial and industrial construction.

With the ability to reduce construction time by up to 50% and cut costs by 10–20%, SG Echo’s manufacturing process emphasizes speed, sustainability, and resilience. In October 2025, SG Echo’s operations were consolidated into a new facility in Conroe, Texas, where they now operate alongside Olenox Corp., a Safe and Green subsidiary focused on oil and gas operations, to streamline logistics and integrate manufacturing with field operations. Revenue is also generated through third-party property leasing at the Conroe site.

SG Modular Medical

SG Modular Medical designs and deploys modular point-of-care solutions tailored for the evolving demands of healthcare infrastructure. The system enables clinics and labs to be rapidly assembled from clinical, administrative, and diagnostic modules, offering adaptability based on local needs and population shifts. This modular approach is positioned as a lower-emission alternative to traditional medical construction, helping reduce the substantial carbon footprint associated with healthcare infrastructure.

Notable deployments include COVID-19 testing pods at Los Angeles International Airport (LAX), designed and delivered in partnership with airport authorities. Another initiative, launched with The Peoples Healthcare and Teamsters Local 848, involves delivering modular clinics to serve union members with onsite, high-quality care staffed by a top-tier clinical operator.

SG Development Corp.

SG DevCorp is the real estate development division of Safe and Green Holdings Corp., focused on building modular single- and multifamily projects across various income levels. The company pursues strong, green developments supported by vertically integrated manufacturing from SG Echo. SG DevCorp has stated development targets of more than 4,000 modular units totaling over 3.2 million square feet across 1,000+ acres of acquired land—a construction pipeline valued at approximately $765 million.

The division prioritizes sustainability throughout the lifecycle of its developments, reducing construction waste, energy usage, emissions, and noise pollution. Its projects aim to minimize the environmental impact while enhancing speed-to-market and structural resilience.

SG Environmental Solutions

SG Environmental Solutions provides modular environmental infrastructure and sustainable waste management technologies. At the core of this division is Sanitec, a patented system designed for medical waste sterilization and volume reduction. The technology helps organizations reduce their environmental impact while significantly lowering operational costs.

The company emphasizes responsible construction and stewardship through upcycling, waste reduction, and adaptable modular deployments. Its container-based platforms are built for diverse use cases across commercial, residential, industrial, and environmental applications, with a focus on high-efficiency, reduced-emission outcomes.

Olenox Energy

Olenox Energy is the energy development arm of Safe and Green Holdings, focused on acquiring and revitalizing distressed oil and gas assets. In May 2025, the company acquired 1,600 acres of wells and leases from Sherman Oil & Gas and its affiliates, adding 111 wells to the Olenox portfolio. Since the acquisition, Olenox has produced over 3,000 barrels of oil and is currently achieving peak production rates of 55 barrels per day. The company is preparing additional workovers to add 25–30 bpd and has completed full asset mobilization into Texas. Olenox also holds a 51% stake in Winchester Oil & Gas, representing more than 500 wells across the state.

The company is executing its strategy to build a fully integrated oil and gas platform. Olenox operations remain in full compliance with the Texas Railroad Commission, with a stated emphasis on environmental stewardship and reduced lease operating expenses.

In September 2025, Safe and Green entered into an Open Collaborative Framework with OneQode, a global digital infrastructure company. The agreement supports joint development of spill detection, real-time telemetry, and command systems for remote energy assets, enhancing Olenox’s operational capabilities through automation and data infrastructure.

Market Opportunity

Safe and Green Holdings is positioned to capitalize on macro trends across multiple sectors. The construction and real estate industries continue to seek faster, greener alternatives to traditional building methods—needs that SG Echo and SG DevCorp address through prefabricated, modular designs. In healthcare, rising demand for scalable care infrastructure underscores the relevance of SG Modular Medical’s point-of-care solutions.

Within energy, Olenox targets long-term value in revitalizing overlooked oil and gas assets. Its operational model, combined with emerging infrastructure technology partnerships, aims to improve field performance while maintaining environmental compliance. Through this diversification, Safe and Green aligns its platform with infrastructure modernization, energy resilience, and sustainability imperatives.

Leadership Team

Michael McLaren, Chairman and Chief Executive Officer, brings over 30 years of leadership in the energy industry, including military and field service projects, mergers and acquisitions, and technology development. He is the founder of Olenox Ltd., a developer of proprietary energy systems, and holds advanced degrees in Science and Business from the University of British Columbia. McLaren has authored multiple papers on alternative fuels and energy systems and serves as a lead strategist for Safe and Green’s cross-sector growth.

Patricia Kaelin, CPA, Chief Financial Officer, has more than 30 years of experience in public company financial management, mergers and acquisitions, and strategic capital deployment. She previously served as CFO and CIO of a billion-dollar construction company overseeing operations across 14 states. Her background spans construction, healthcare, manufacturing, and real estate. Kaelin holds a bachelor’s degree in business administration with a concentration in accounting from California State University, Fullerton.

Jim Pendergast, Chief Operating Officer, has held executive leadership roles across multiple sectors, including energy, construction, and agriculture. He has served as COO, CFO, and CEO at public and private firms, overseeing operations, acquisitions, and project execution. He holds an MBA in international business and finance from McMaster University and a BA in political studies and economics from Queen’s University.

Investment Considerations
  • Olenox operates a vertically integrated business across modular construction, environmental solutions, healthcare, and energy.
  • SG Echo’s relocation and consolidation into a new Texas facility supports streamlined manufacturing and operational synergy with Olenox Energy.
  • Olenox has delivered strong early production results and continues to expand its U.S. energy footprint through strategic acquisitions and field revitalization.
  • SG Modular Medical has deployed real-world installations at major public sites such as LAX and is working with nonprofit and labor organizations on scalable healthcare delivery.
  • The company’s environmental division leverages proprietary Sanitec technology to provide sustainable, cost-reducing solutions for medical waste management.

Olenox Industries Inc. (NASDAQ: OLOX), closed Tuesday's trading session at $1.06, off by 2.7523%, on 173,780 volume. The average volume for the last 3 months is 673,236 and the stock's 52-week low/high is $0.9516/$96.

Recent News

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of mineral properties worldwide, just completed and delivered a comprehensive ANT-based 3D geological model for its Montauban Project

The model illustrated mineralized architecture extending to depths of approximately 900 meters and 2 kilometres in length, with mineralized trends only bounded by the limits of existing ANT coverage

It marks a pivotal milestone in the company's evolution from a legacy mining site into a project with district-scale exploration potential

Going forward, ESGold looks to validate the interpretations through expanded geophysics and targeted stepout drilling

ESGold (CSE: ESAU) (OTCQB: ESAUF) , a development-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, just marked a significant milestone with the completion and delivery of a comprehensive Ambient Noise Tomography ("ANT")-based 3-dimensional ("3D") geological model for its Montauban Project in Québec. Prepared by Geomatic World Inc. in collaboration with CAUR Technologies , this model marks a pivotal milestone in the company's evolution from a legacy mining site into a project with district-scale exploration potential advancing in parallel with near-term tailings production in 2026.

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

Investment Considerations
  • Fully Permitted & Funded for Near-Term Production: Construction underway soon at Montauban with gold-silver production expected in Q3 2025.
  • Tailings-to-Cashflow Strategy: Near-term cash flow from processing historic tailings will fund exploration across the district-scale land package.
  • Replicable Clean Mining Model: Scalable approach to legacy mine redevelopment in Canada and globally.
  • Broken Hill Analogue: Geological and structural parallels suggest Montauban may host a larger, mineralized system at depth.
  • Modern 3D Imaging Tech: Cutting-edge ANT survey is producing subsurface imaging beyond 800m, uncovering the potential size of the deposit.

ESGold Corp. (OTCQB: ESAUF), closed Tuesday's trading session at $0.57, off by 0.1751314%, on 103,780 volume. The average volume for the last 3 months is 219,690 and the stock's 52-week low/high is $0.139/$1.1.

Recent News

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF)

The QualityStocks Daily Newsletter would like to spotlight Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF).

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) announced additional analytical results from its 2025 maiden drilling program at the satellite West Santa Fe project in Nevada's Walker Lane, reporting results from two reverse-circulation rotary drill holes that continue to validate historic drilling and demonstrate fault-controlled oxide gold and silver mineralization. Highlights include hole WSF25-03R intersecting 41.2 metres grading 1.94 g/t Au Eq, including 9.1 metres at 4.14 g/t Au Eq, with individual intercepts up to 12.88 g/t Au Eq, and hole WSF25-01R intersecting 6.1 metres grading 1.53 g/t Au Eq at the eastern extent of the south mineralized zone, which remains open to the east, with additional drill results expected shortly.

To view the full press release, visit https://ibn.fm/j1dAw

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) is a Canadian mine development and exploration company advancing a portfolio of gold and silver assets in Nevada’s Walker Lane, one of the world’s most productive and mining-friendly regions. Through its U.S. subsidiaries, the company controls four gold and silver properties in Nevada, three of which are 100%-owned and one controlled via a low-cost option to acquire full ownership. With a clear near-term path to production, Lahontan is focused on unlocking oxide gold and silver value from past-producing, infrastructure-rich projects.

The company’s mission is to responsibly develop and expand its oxide resources while minimizing capital intensity and maximizing economic returns. Leveraging a strong technical team with a track record of advancing projects and building mines, Lahontan is focused on growing gold and silver resources and hitting permitting milestones across multiple sites. Its strategy prioritizes scalability, efficiency, and timely value realization for shareholders.

By maintaining full project ownership and a capital-light development model, Lahontan Gold is positioned to rapidly transition from development to production.

The company is headquartered in Toronto, Ontario.

Projects

Santa Fe Mine

The 26.4 km² Santa Fe Mine is Lahontan’s flagship asset and core development priority. A past-producing open-pit, heap-leach gold and silver operation, Santa Fe historically yielded more than 359,000 ounces of gold and 702,000 ounces of silver between 1988 and 1995. The site benefits from established infrastructure—including power, water, and road access—and more than 79% of its known resources are unencumbered by royalties.

A 2024 NI 43-101 resource estimate outlines 1.54 million ounces of gold equivalent (AuEq) in the Indicated category and 0.41 million ounces Inferred, all pit-constrained. Oxide resources average among the highest grades in the state and are distributed across five known deposits. A 2025 Preliminary Economic Assessment (PEA) projects strong economic returns, including an after-tax NPV5% of $200 million, a 34.2% internal rate of return (IRR), and average annual production of approximately 50,000 ounces AuEq over an eight-year mine life.

Permitting is well underway for both the Exploration and Mine Plans of Operation, covering over 12 km² and more than 700 drill holes. The company is targeting construction permits in late 2026 and continues to pursue oxide resource expansion and metallurgical optimization, particularly within the Slab-Calvada corridor.

West Santa Fe

West Santa Fe lies just 13 kilometers from the flagship and is being explored as a potential satellite operation. The project is defined by a shallow, oxide-dominant gold-silver system with a conceptual target of 0.5 to 1.0 million ounces AuEq based on historic drilling and recent surface sampling, which returned up to 2.61 g/t Au and 899 g/t Ag (14.6 g/t AuEq). A 6,300-meter Phase One reverse circulation drill program is scheduled for 2025 to validate historical data and support a maiden resource estimate. Development is streamlined under a low-cost option agreement and a rapid permitting path via Notice of Intent.

Moho and Redlich

The Moho and Redlich projects provide additional longer-term upside within Lahontan’s portfolio. Moho features high-grade, oxidized epithermal veins with historic production at grades of 20–25 g/t Au and 300 g/t Ag. A 2019 core drill program confirmed the presence of high-grade mineralization at depth. Redlich, located along trend from the historic Candelaria silver mine, hosts disseminated Ag mineralization in epithermal veins and hydrothermal breccias but remains untested by drilling. While no near-term programs are currently disclosed, both assets represent future exploration optionality.

Market Opportunity

Lahontan Gold operates in Nevada, consistently ranked the top global mining jurisdiction by the Fraser Institute due to its transparent permitting process, legal stability, and established infrastructure. Nevada produces over 4.5 million ounces of gold annually, generating approximately $9 billion in value, and ranks fifth globally in total gold production.

According to the World Gold Council, total gold demand in Q1 2025 reached 1,206 tonnes, up 1% year-over-year, marking the strongest first quarter since 2016. Central banks added 244 tonnes to reserves, a slight slowdown from the prior quarter but well within the strong buying range observed over the past three years. Meanwhile, silver demand is supported by strong industrial usage in solar panels, electric vehicles, and semiconductors, with long-term deficits forecast in the physical silver market.

With macro-driven demand for gold, technology-driven silver consumption, and strong institutional buying across both metals, Lahontan is uniquely positioned to capitalize through its portfolio of oxide-focused projects in a top-tier jurisdiction—offering near-term production potential and longer-term resource expansion.

Leadership Team

Kimberly Ann, Founder, CEO, President & Executive Chair, is a veteran mining executive with a track record of founding and scaling junior resource companies. She has raised over $210M in financing and led the $340M buyout of Prodigy Gold. Her prior roles include CFO of PPX Mining and founder of Latin America Resource Group, which merged with Carube Copper to form C3 Metals.

Brian Maher, Founder and VP of Exploration, is an economic geologist with more than 45 years of experience. He previously led Prodigy Gold as CEO, where he helped develop the Magino gold project before its $341M acquisition. His career includes senior roles at ASARCO, Hochschild Mining, and PPX Mining, where he oversaw exploration and production in the Americas.

John McNeice, Chief Financial Officer, is a Chartered Professional Accountant with three decades of experience in public company reporting. He has served as CFO for seven public resource companies and played a key role in Ur-Energy Inc.’s TSX IPO and $150M in financings. He also serves as CFO for Gold79 Mines, C3 Metals, and Northern Graphite Corp.

Current Initiatives
  • Commencing Summer gold and silver resource expansion drilling at Santa Fe
  • Optimizing Preliminary Economic Assessment reflecting +$3,000 gold price
  • Exploration Plan of Operations heading into NEPA stage with approval expected Q4 2025
  • Targeting late 2026 mining permit and breaking ground at Santa Fe in 2027
Investment Considerations
  • The Santa Fe Mine hosts 1.95 million ounces of pit-constrained gold equivalent resources across Indicated and Inferred categories.
  • A 2025 Preliminary Economic Assessment for Santa Fe outlines an after-tax NPV5% of $200 million and a 34.2% IRR based on spot pricing.
  • All four projects are 100%-owned or under low-cost acquisition agreements, with development centered in Nevada, the world’s top mining jurisdiction.
  • Near-term catalysts include Santa Fe permitting milestones, West Santa Fe’s maiden drill program, and an updated economic study.
  • The company is led by a proven team with multiple M&A exits and extensive experience in advancing heap-leach gold operations.

Lahontan Gold Corp. (OTCQB: LGCXF), closed Tuesday's trading session at $0.22836, off by 0.496732%, on 1,456,520 volume. The average volume for the last 3 months is 2,161,970 and the stock's 52-week low/high is $0.0179/$0.25.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.